The effect of HIV status on clinical outcomes of surgical sepsis in KwaZulu-Natal Province, South Africa by Green, S et al.
702       August 2017, Vol. 107, No. 8
RESEARCH
The HIV epidemic has existed for more than three decades and the 
prevalence in sub-Saharan Africa is one of the highest in the world, 
accounting for ~70% of the global burden of disease.[1] The estimated 
overall HIV prevalence rate is ~11% of the total South African (SA) 
population. KwaZulu-Natal (KZN) Province in SA is at the epicentre 
of this pandemic.[2,3] About 25% of the province’s adult population live 
with the virus, compared with a national average of 18%.[4] In KZN, 
there are districts with higher rates of infection, e.g. Amajuba district, 
where 47% of women attending antenatal clinics tested positive, while 
51% of women aged 25 - 29 years who participated in a household 
survey in the rural district of Umkhanyakude were found to be HIV-
positive.[5] Surveys in Eshowe and Mbongolwane districts, conducted 
by Médecins Sans Frontières (MSF), reported that women were the 
most affected by the disease, with 56% aged between 30 and 39 years 
currently living with HIV.[6]
The introduction of highly active antiretroviral treatment (HAART) has 
extended the life expectancy of individuals who are HIV-infected, effec-
tively changing infection with this retrovirus from a lethal condition to a 
manageable chronic disease. Increasing numbers of HIV-infected patients, 
therefore, present with medical and surgical conditions similar to those 
seen in HIV-negative patients. Recent studies have shown that irrespective 
of the use of HAART, sepsis among HIV-infected patients is increasing, 
while the incidence of acute respiratory insufficiency and Pneumocystis-
related pneumonia is decreasing.[7-9] In HIV-infected patients, sepsis 
accounted for 12 - 31% of HIV-positive patients’ admission to intensive 
care units (ICUs), and was associated with a worse prognosis.[7-10] 
Despite the significant prevalence of the disease in KZN, the impact 
of HIV co-infection on the clinical outcome of surgical patients 
in our setting remains largely unknown. Over a decade ago, and 
prior to the national roll-out of the HAART programme, a study by 
Cacala et al.[2] showed that HIV status does not influence the clinical 
outcome in general surgical patients. Their study included trauma 
and non-trauma patients, and did not focus solely on the outcome of 
HIV-infected patients with surgical sepsis. Since the national HAART 
programme, there has been no subsequent documentation in the 
literature on the outcome of HIV infection in surgical patients. More 
specifically, there has not been any documentation on the outcome of 
surgical sepsis in HIV-infected patients in KZN. 
Surgical sepsis is a broad term that covers a spectrum of conditions 
where patients have a septic process that requires surgical source 
control. The current understanding of the impact of sepsis on HIV-
infected patients is limited, even though, despite the significant 
increase in survival and quality of life, HIV/AIDS patients have been 
systematically excluded from sepsis studies.[7] 
The study objective was to review and quantify the differences in 
clinical course and outcome between HIV-positive and HIV-negative 
patients with primary surgical sepsis in a major university hospital in SA. 
Methods
Clinical setting 
This was a retrospective study undertaken at the Pietermaritzburg 
Metropolitan Surgical Service (PMSS) based at Grey’s and Edendale 
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outcome with those without HIV infection. 
Methods. A retrospective study was undertaken at the Pietermaritzburg Metropolitan Surgical Service (PMSS), SA over a 5-year period 
from January 2010 to December 2014.
Results. A total of 675 patients with a documented surgical source of sepsis were reviewed. Of these, 332 (49%) were male, and the mean age 
was 46 (standard deviation 19) years. HIV status was known in 237 (35%) patients, 146 (62%) were HIV-positive and the remaining 91 (38%) 
were HIV-negative. Other than tuberculosis of the abdomen being significantly more common in HIV-positive than HIV-negative patients 
(10% v. 2%, p=0.033), there were no differences in the spectrum of diseases between the two groups. There were no significant differences in 
overall morbidity or mortality. When adjusted for CD4 counts, the mortality in HIV-positive patients with a CD4 count <200 cells/µL was 
60% (15/25) and in those with a CD4 count >200 cells/µL it was 2% (2/101) (p<0.001). 
Conclusion. The clinical presentation and the spectrum of surgical sepsis in patients with HIV co-infection were not markedly different to 
those in patients who were not HIV-infected. HIV-infected patients with a CD4 count <200 cells/µL had a significantly higher mortality. 
Management approaches should not differ based solely on the HIV status of patients with surgical sepsis. 
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hospitals, Pietermaritzburg, SA. Our regional electronic registry was 
reviewed – from January 2010 to December 2014. KZN is located 
along the east coast of the country, with a population of >11 million; 
50% of the population live in rural areas. The PMSS provides definitive 
surgical care to the city of Pietermaritzburg, the capital of KZN 
Province. It also serves as the referral centre for 19 other rural hospitals 
in the province, with a total catchment population of >3 million. [11]
The study
All adult emergency general surgical patients (>15 years of age), who 
were admitted by the PMSS, were reviewed. All patients fulfilling 
the American College of Chest Physicians/Society of Critical Care 
Medicine Consensus criteria for sepsis, severe sepsis or septic 
shock,[12] and with a documented surgical source of infection, were 
reviewed. According to these criteria, sepsis is defined as a complex 
systemic inflammatory response syndrome (SIRS) to infection; severe 
sepsis is defined as a systemic inflammatory syndrome in response to 
infection that is associated with acute organ dysfunction; and septic 
shock is defined as sepsis with refractory hypotension (systolic blood 
pressure <90 mmHg or mean arterial pressure <70 mmHg, despite 
resuscitation with 30 mL/kg of crystalloid). SIRS comprises two or 
more of the following:
• temperature >38°C or <36°C
• pulse >90 beats/minute
• respiratory rate >20 breaths/minute or PaCO2 <32 mmHg
• white cell count >12 ×109/L or >10% immature band forms.
Only surgical patients with a hospital record with laboratory docu-
mentation of HIV status were included. As this was a retrospective 
study based on a prospectively maintained database, no patients were 
tested as a part of the study. Routine clinical care information was 
obtained from the database and patients’ medical records. 
All patients with incomplete records or without a proven surgi-
cal source of sepsis were excluded. Data from the registry included 
basic demographic information, admission physiological parameters, 
and diagnosis. Clinical outcomes were described in terms of the need 
for ICU admission, length of hospital stay, morbidity and mortality. 
Complications during hospitalisation and not related to the primary rea-
son for surgical treatment, were further grouped by organ systems (e.g. 
hospital-acquired pneumonia was classified as respiratory complications, 
acute kidney injury as renal complications, and surgical site infection as 
wound complications). The surgical pathologies were classified into the 
following categories: intra-abdominal sepsis, limb sepsis, and soft-tissue 
sepsis. All patients who were proven to be HIV-positive were compared 
with those who were known to be HIV-negative. Further subgroup com-
parisons were made in HIV-positive patients based on their CD4 counts 
(CD4 <200 cells/μL or >200 cells/μL). A CD 4 count <200 cells/μL corre-
sponds to stage III disease; a count greater than this is stage II or I disease. 
Statistical analysis
Data were processed and analysed using Stata 13.0 (StataCorp., USA). 
Continuous variables were summarised using means and standard 
deviations (SDs). If there was evidence of skewing/asymmetrical 
outliers, the median and interquartile range (IQR) were presented 
instead. Categorical variables were summarised using frequencies 
and percentages. Differences in means and ranks (if skewed/non-
normal) of continuous variables by HIV status were assessed using 
Student’s t-test and Wilcoxon’s rank-sum test (Mann-Whitney 
U-test), respectively. An association between categorical explanatory 
variables and HIV status was assessed using Pearson’s χ2 test or 
Fisher’s exact test if there were ˂5 observations in any cell. A p-value 
˂0.05 was considered statistically significant.
Ethical approval
Ethical approval for this study and for maintenance of the registry 
was endorsed by the Biomedical Research Ethics Committee of the 
University of KZN (ref. no. BE 207/09 and BCA 221/13).
Results 
Demographic characteristics 
During the 5-year study period, 675 patients with a documented 
surgical source of sepsis were reviewed. Of these, 332 (49%) were 
male and the mean age was 46 (SD 19) years. Of the cohort of 675 
patients, the HIV status was known in 237 (35%). Of these, 146 (62%) 
were HIV-positive and 91 (38%) were HIV-negative. The status of the 
remaining 438 was unknown and was not considered further. The 
demographics of the HIV-positive and HIV-negative group are given 
in Table 1. There were significantly more female and rural patients, as 
well as concomitant tuberculosis (TB) among HIV-positive patients 
compared with those who were HIV-negative. 
Clinical presentation and disease spectrum
The clinical characteristics of the patients are summarised in Table 2. 
The disease spectrum for both groups is given in Table 3. TB of the 
abdomen was significantly more common in HIV-positive than HIV-
negative patients (10% v. 2%, p=0.033). Of the total 237 patients, 194 
(82%) required operative procedures for source control ( HIV-positive 
v. HIV-negative patients (78% (114/147) v. 88% (80/91), p=0.045). 
Table 4 summarises operative interventions for source control in both 
groups. 
Clinical outcomes
Table 5 compares the number of patients with morbidities (by organ 
system) and the length of hospital stay between HIV-positive and 
HIV-negative patients. Some patients had more than one organ 
system complication, while others had no complications. There were 
no significant differences in overall morbidity or mortality between 
these patients. 
Mortality by CD4 count 
Among the HIV-positive patients with a CD4 count <200 cells/µL or 
stage III disease, mortality was 60% (15/25), while that in patients 
with HIV and a CD4 count >200 cells/µL (stage II and stage I disease) 
was 2% (2/101). This was highly statistically significant (p<0.001). 
Discussion
The high prevalence of HIV in KZN results in a significant number 
of patients presenting with an acute surgical illness together with 






(N=91), n (%) p-value 
Age (years),  
mean (SD) 
37 (11) 40 (17) 0.052
Male 57 (39) 50 (55) 0.017*
Female 89 (61) 41 (45)
Rural 79 (54) 67 (74) 0.003*
Urban 67 (46) 24 (26)
Active TB 35 (24) 6 (7) 0.001*
TB = tuberculosis.
*t-test for comparison of age, and Pearson’s χ2 test for comparison of categorical variables by 
HIV status.
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HIV co-infection.[1-3] Patients may present 
with a complication due to their chronic 
immunosuppressed state or with an unrelated 
surgical illness. Immunosuppression results 
in opportunistic infections such as TB and a 
number of viral infections. In our study, very 
few patients presented with specific surgical 
complications of HIV – the most common 
HIV-associated cause of surgical sepsis was 
abdominal TB. 
Other than TB of the abdomen being 
significantly more common in HIV-positive 
patients, there was no difference in the spec-
trum of disease. There were no complica-
tions of visceral vasculopathy, HIV- related 
cholangiopathy or colitis. This is consistent 
with the literature, indicating that TB is the 
overwhelming opportunistic infection asso-
ciated with HIV disease in Africa.[13-15] Our 
study showed no significant differences in 
overall morbidity or mortality between HIV-
infected and HIV-uninfected patients. This 
is in contrast to the documented poorer out-
come of sepsis in HIV-infected patients.[7-10] 
In these studies, no differentiation is made 
between patients with surgical sepsis and 
those without. 
Sixty-two percent of our study patients 
with known results were HIV-positive, 
which is higher than the reported average 
prevalence (25.2%) of HIV in KZN.[4] This 
might be due to our study having significantly 
more females and more rural patients, and 
may reflect documented regional differences 
in the prevalence of HIV infection.[5,6]
The management of patients with a surgi-
cal disease and HIV co-infection remains 
controversial. Many have suggested that HIV 
co-infection places surgical patients at risk of 
major morbidity and have advocated a mini-
malistic and ultimately fatalistic approach to 
patients with acute surgical emergencies. This 
view was first challenged by Bhag wan jee et al. [3] 
at King Edward VIII Hospital in Durban. In his 
controversial prospective trial, it was shown 
that HIV co-infection appeared to offer a 
protective advantage to patients admitted to 
the surgical ICU. It was postulated that the 
immunosuppression inherent in HIV infec-
tion dampened down the septic response to 
critical illness. A decade later, Cacala et al.,[2] 
from Prince Mshiyeni Memorial Hospital in 
Durban, showed that HIV status does not 
influence the outcome of general surgical 
admissions and should not influence surgi-
cal management decisions. These authors 
reported that in their heterogeneous popula-
tion of HIV-positive surgical patients, CD4 
counts were unrelated to outcome. Both these 
studies were from the era prior to the roll-out 
of the national HAART programme. In gene-
ral, CD4 count is regarded as being a proxy 





Characteristics Median (IQR) Median (IQR) p-value*
Systolic BP (mmHg) 114 (104 - 127) 118 (107 - 136) 0.083
Diastolic BP (mmHg) 68 (58 - 80) 71 (62 - 82) 0.299
Mean arterial pressure (mmHg) 84 (74 - 95) 87 (78 - 96) 0.111
GCS on admission 15 (15 - 15) 15 (15 - 15) 0.620
Respiratory rate (breaths/min.) 20 (16 - 24) 20 (18 - 24) 0.682
Heart rate (beats/min.) 111 (97 - 121) 107 (94 - 120) 0.316
White cell count (109/L) 16 (11 - 21) 16 (12 - 22) 0.303
BP = blood pressure; GCS = Glasgow coma score; IQR = interquartile range.
*Wilcoxon rank-sum (Mann-Whitney U-test).
Table 3. Source of sepsis for HIV-positive v. HIV-negative patients 




(N=91), n (%) p-value
Appendicitis 34 (23) 25 (27) 0.451
Abdominal tuberculosis 14 (10) 2 (2) 0.033*
Biliary sepsis 13 (9) 6 (7) 0.534
Other intra-abdominal sepsis* 22 (15) 13 (14) 0.885
Perforated peptic ulcer 11 (7) 7 (8) 0.953
Non-diabetic limb sepsis 10 (7) 8 (9) 0.573
Necrotising fasciitis 9 (6) 7 (8) 0.638
Pelvic inflammatory disease 7 (5) 3 (3) 0.745
Diabetic limb sepsis 6 (4) 7 (8) 0.234
Head and neck abscess 5 (3) 4 (4) 0.735
Peri-anal sepsis 5 (3) 0 (0) 0.160
Limb abscess 4 (3) 2 (2) 1.000
Intra-abdominal abscess 4 (3) 3 (3) 1.000
Trunk abscess 3 (3) 4 (4) 0.433
*Other intra-abdominal sepsis includes perforation of small or large bowel, infective colitis and bowel ischaemia with intra-
abdominal soiling.





(N=80), n (%) p-value
Laparotomy 69 (61) 39 (49) 0.104
Debridement 7 (6) 9 (11) 0.203
Amputation 12 (11) 13 (16) 0.241
Laparoscopic cholecystectomy 2 (2) 0 (0) 0.513
Incision and drainage 13 (11) 11 (14) 0.625
Radiological drainage 4 (4) 1 (1) 0.650
ERCP 3 (3) 3 (4) 0.692
Appendicectomy 3 (3) 4 (5) 0.450
Open cholecystectomy 1 (1) 0 (0) 1.000
Total 114/147 (78) 80/91 (88) 0.045* 
ERCP = endoscopic retrograde cholangiopancreatography.
*Fisher’s exact test.
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marker for immune function. In our study, a 
significant difference in outcome was noted 
between HIV patients with a CD4 count 
<200 cells/µL and those with CD4 counts 
>200 cells/µL. HIV-infected individuals with 
surgical sepsis and a CD4 count ˂200 cells/ 
µL are 36 times more likely to die than HIV-
infected patients who have a CD4 count 
>200 cells/µL. These findings differ from those 
of Caca la et al.[2] Our findings were consistent 
with those in the litera ture.[16,17] Feng et al.[18] 
used logistic regression to determine risk fac-
tors for the development of sepsis in surgical 
patients with HIV-infection, with and with-
out sepsis. They reported that in HIV-infected 
patients who required surgery for malignancy 
or sepsis, those with a low CD4 count and 
with hypoalbuminaemia before surgery, had a 
higher probability of developing postoperative 
sepsis. Further studies are required to define 
the impact of CD4 counts on other aspects of 
clinical outcome in surgical patients with sepsis.
Conclusion 
The clinical presentation and spectrum of 
surgical sepsis disease in patents with HIV co-
infection were not markedly different to those 
in patients who are not infected with HIV. In 
patients with a CD4 count ˂200 cells/µL, the 
mortality was significantly higher. 
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Table 5. Complications (by organ system) and duration of hospital stay in HIV-





(N=91), n (%) p-value*
Neurological 0 (0) 0 (0) -
Respiratory 16 (11) 11 (12) 0.790
Wound 16 (11) 10 (11) 0.994
Renal 11 (8) 3 (3) 0.259
Gastrointestinal 11 (8) 3 (3) 0.259
Cardiac 2 (1) 1 (1) 1.000
Urinary 0 (0) 0 (0) -
Length of stay in hospital (days), median (IQR) 6 (3 - 11) 6 (4 - 12) 0.669
Mortality 17 (12) 9 (10) 0.669
* Pearson’s χ2 test for comparison of categorical variables or Fisher’s exact test if <5 observations in any cell; Wilcoxon’s signed-
rank test.
